Abstract
The overall aim of this chapter is to review the literature regarding the experiences of primary caregivers (i.e., family members who care for a person with Alzheimer disease) and decisions about drug therapy. Specifically, the purpose is to describe the experience of acetylcholinesterase inhibitor (AChEI) therapy of primary caregivers of persons with Alzheimer disease (AD), outline the inherent ethical issues that are part of drug therapy decisions, and suggest areas for future, empirical research.
| Original language | English |
|---|---|
| Title of host publication | Ethical Foundations of Palliative Care for Alzheimer Disease |
| Publisher | The Johns Hopkins University Press |
| Pages | 330-342 |
| Number of pages | 13 |
| ISBN (Print) | 0801878705, 9780801898396 |
| State | Published - 2010 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Arts and Humanities(all)
Cite this
Drugs and dementia : Pharmacotherapy and decision making by primary caregivers. / Haddad, Amy M.
Ethical Foundations of Palliative Care for Alzheimer Disease. The Johns Hopkins University Press, 2010. p. 330-342.Research output: Chapter in Book/Report/Conference proceeding › Chapter
}
TY - CHAP
T1 - Drugs and dementia
T2 - Pharmacotherapy and decision making by primary caregivers
AU - Haddad, Amy M.
PY - 2010
Y1 - 2010
N2 - The overall aim of this chapter is to review the literature regarding the experiences of primary caregivers (i.e., family members who care for a person with Alzheimer disease) and decisions about drug therapy. Specifically, the purpose is to describe the experience of acetylcholinesterase inhibitor (AChEI) therapy of primary caregivers of persons with Alzheimer disease (AD), outline the inherent ethical issues that are part of drug therapy decisions, and suggest areas for future, empirical research.
AB - The overall aim of this chapter is to review the literature regarding the experiences of primary caregivers (i.e., family members who care for a person with Alzheimer disease) and decisions about drug therapy. Specifically, the purpose is to describe the experience of acetylcholinesterase inhibitor (AChEI) therapy of primary caregivers of persons with Alzheimer disease (AD), outline the inherent ethical issues that are part of drug therapy decisions, and suggest areas for future, empirical research.
UR - http://www.scopus.com/inward/record.url?scp=33749334230&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33749334230&partnerID=8YFLogxK
M3 - Chapter
AN - SCOPUS:33749334230
SN - 0801878705
SN - 9780801898396
SP - 330
EP - 342
BT - Ethical Foundations of Palliative Care for Alzheimer Disease
PB - The Johns Hopkins University Press
ER -